Related Experiment Video
Updated: Oct 29, 2025
06:03
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
1.5K
SARS-CoV-2 Infection: Differences in Hematological Parameters Between Adults and Children.
Lanqin Liu1,2, Jiatong She3, Yongqi Bai1,2,3
1Department of Pediatric Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China.
International Journal of General Medicine
|July 8, 2021
Summary
Hematological parameters differ between adult and pediatric COVID-19 patients. Understanding these differences in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection aids in assessing disease severity and prognosis.
Area of Science:
- Hematology
- Infectious Diseases
- Pediatrics
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, presents a significant global health challenge.
- Hematological parameters offer insights into SARS-CoV-2-induced damage to blood cells, aiding in severity assessment and prognosis.
- Distinct hematological profiles exist between adult and pediatric populations infected with SARS-CoV-2.
Purpose of the Study:
- To comprehensively review and highlight the differences in hematological parameters between adult and pediatric patients with SARS-CoV-2 infection.
- To provide a comparative analysis of hematological findings in COVID-19 across different age groups.
- To establish a reference for diagnosing and managing COVID-19 in children and adults.
Main Methods:
- Systematic literature review focusing on studies reporting hematological parameters in COVID-19 patients.
- Comparative analysis of key hematological indices (e.g., white blood cell counts, lymphocyte counts, platelet counts, inflammatory markers) in adult versus pediatric cohorts.
- Synthesis of findings to identify age-specific patterns and variations.
Main Results:
- Adults with COVID-19 often exhibit lymphopenia, elevated inflammatory markers, and varying degrees of leukopenia or leukocytosis.
- Children with COVID-19 may present with milder hematological abnormalities, including less pronounced lymphopenia and a higher prevalence of neutrophilia in some cases.
- Specific differences were noted in red blood cell parameters and coagulation markers between the age groups.
Conclusions:
- Hematological parameters serve as crucial indicators for COVID-19 severity and prognosis, with notable age-dependent variations.
- Recognizing these pediatric-adult differences is essential for accurate clinical assessment and tailored treatment strategies.
- Further research is warranted to elucidate the underlying mechanisms driving these hematological distinctions in SARS-CoV-2 infection.
More Related Videos
Related Concept Videos
01:20Overview of Hematopoiesis
5.9K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
5.9K
01:21Hematopoiesis
7.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
7.3K